455
Participants
Start Date
November 30, 2008
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Saxagliptin, 5 mg + insulin
Saxagliptin, 5-mg tablets (plus stable insulin dose), given orally once daily (24 weeks short-term, 28 weeks long-term); participants stratified by use of stable metformin dose; flexible insulin dose (as needed for rescue)
Placebo + insulin
Placebo tablets given orally once daily for 24 weeks (short-term period)+ insulin with metformin
Local Institution, Budapest
Local Institution, Budapest
Local Institution, Budapest
Local Institution, Parktown
Local Institution, Durban
Local Institution, Umhlanga
Local Institution, Szentes
Local Institution, Goodwood
Local Institution, Tygerberg
Local Institution, Balatonfüred
Local Institution, Zalaegerszeg-Pozva
Local Institution, Mexico City
Southgate Medical Group, West Seneca
Local Institution, Aguascalientes
Local Institution, Aguascalientes
Local Institution, Besançon
Southeastern Research Associates, Inc., Taylors
Endocrine Research Solutions, Inc., Roswell
Family Care Associates Of Nw Florida, Chipley
Panhandle Family Care Assoc. & Coastal Palms Res. Grp Inc., Marianna
Central Florida Clinical Trials, Inc., Altamonte Springs
Local Institution, Montpellier
Danny W. Jackson P.A., Rolling Fork
Local Institution, Nantes
Local Institution, Zapopan, Jal.
Aurora Advanced Healthcare, Milwaukee
Local Institution, Valenciennes
Local Institution, Monterrey
Local Institution, Monterrey
Local Institution, Monterrrey
Local Institution, Monterrey
Texas Center For Drug Development, Houston
Dgd Research, Inc., San Antonio
Clinical Research Advantage, Inc, Tempe
Torrance-Lomita Medical Center, Lomita
Diabetes Medical Center Of California, Northridge
Local Institution, Veracruz
Encompass Clinical Research, Spring Valley
Ritchken & First M.D.'S, San Diego
Valley Research, Fresno
Local Institution, Hariyāna
Local Institution, Yaroslaval
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Smolensk
Local Institution, Kursk
Local Institution, Mumbai
Local Institution, Saratov
Local Institution, Pune
Local Institution, Pune
Local Institution, Indore
Local Institution, Vellore
Local Institution, Calgary
Local Institution, Vancouver
Local Institution, Bathurst
Local Institution, London
Local Institution, Charlottetown
Local Institution, Gatineau
Local Institution, Laval
Local Institution, Sherbrooke
Local Institution, Regina
Local Institution, Pune
Local Institution, Mexico City
Local Institution, Elblag
Local Institution, Gdansk
Local Institution, Krakow
Local Institution, Lodz
Local Institution, Lublin
Local Institution, Sopot
Local Institution, Szczecin
Local Institution, Wroclaw
Local Institution, Zabrze
Local Institution, Middlesbrough
Local Institution, Salford
Local Institution, Newcastle upon Tyne
Local Institution, Birmingham
Local Institution, Sheffield
Lead Sponsor
AstraZeneca
INDUSTRY